Does DEFERASIROX Cause Myelodysplastic syndrome? 212 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 212 reports of Myelodysplastic syndrome have been filed in association with DEFERASIROX (Deferasirox). This represents 1.9% of all adverse event reports for DEFERASIROX.
212
Reports of Myelodysplastic syndrome with DEFERASIROX
1.9%
of all DEFERASIROX reports
166
Deaths
79
Hospitalizations
How Dangerous Is Myelodysplastic syndrome From DEFERASIROX?
Of the 212 reports, 166 (78.3%) resulted in death, 79 (37.3%) required hospitalization, and 5 (2.4%) were considered life-threatening.
Is Myelodysplastic syndrome Listed in the Official Label?
Yes, Myelodysplastic syndrome is listed as a known adverse reaction in the official FDA drug label for DEFERASIROX.
What Other Side Effects Does DEFERASIROX Cause?
Death (1,583)
Diarrhoea (993)
Serum ferritin increased (732)
Haemoglobin decreased (615)
Pyrexia (607)
Malaise (605)
Nausea (603)
Sickle cell anaemia with crisis (570)
Vomiting (520)
Pneumonia (494)
What Other Drugs Cause Myelodysplastic syndrome?
CYCLOPHOSPHAMIDE (1,545)
LENALIDOMIDE (1,285)
DOXORUBICIN (1,236)
RITUXIMAB (1,054)
VINCRISTINE (966)
ETOPOSIDE (936)
DEXAMETHASONE (759)
METHOTREXATE (728)
CYTARABINE (715)
CARBOPLATIN (698)
Which DEFERASIROX Alternatives Have Lower Myelodysplastic syndrome Risk?
DEFERASIROX vs DEFERIPRONE
DEFERASIROX vs DEFEROXAMINE
DEFERASIROX vs DEFIBROTIDE
DEFERASIROX vs DEFLAZACORT
DEFERASIROX vs DEGARELIX